.AstraZeneca execs claim they are "certainly not concerned" that the breakdown of tozorakimab in a s...
.Welcome to this week's Chutes & Ladders, our summary of considerable management hirings, firings...
.After exposing programs to attack the U.S. social markets less than a month ago, Zenas Biopharma an...
.Psyence Biomedical is actually paying out $500,000 in allotments to get fellow psilocybin-based bio...
.5 months after endorsing Energy Therapies' Pivya as the very first new therapy for easy urinary sys...
.Eli Lilly has vaulted into an AI-enabled medication breakthrough offer, partnering along with RNA p...
.Lykos CEO and owner Amy Emerson is actually stepping down, with chief running policeman Michael Mul...
.Novartis levels a new outpost in its own cooperation with Voyager Rehabs, paying $15 thousand to ta...
.On the heels of an FDA rejection for its own primary competing Novo Nordisk, Eli Lilly is actually ...
.Simply a few months after dosing the first client in a period 2 trial for recently diagnosed gliobl...